Wrinkle fillers to undergo review
- Share via
The safety of skin wrinkle fillers from companies led by Medicis Pharmaceutical Corp. and Allergan Inc. will be reviewed by a U.S. advisory panel next month.
Food and Drug Administration advisors will meet Nov. 18 in Gaithersburg, Md., to hear safety concerns and recommend studies for existing and new wrinkle treatments, according to a notice posted on the agency’s website.
The next day, the advisory panel will discuss evaluation of cosmetic devices that use various energy sources to treat skin conditions.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
